Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs LIV by WellNow

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and LIV by WellNow head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 107 · Grade C

LIV by WellNow

Visit LIV by WellNow Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 74 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make LIV by WellNow a bad call — it's best for patients in its six-state service area who want bundled virtual follow-up and can confirm the dose tier and cancellation terms before paying. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
78
Supply Reliability
95
68
Transparency
90
88
Access Breadth
93
52
Clinical Oversight
92
79
Track Record
88
77
CoreAge RxBrief Score 94 · 74LIV by WellNow

Price, coverage & the tracker

CoreAge RxLIV by WellNow
Brief Score94/100 (A)74/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$195/mo; higher-dose tier $265/mo

Quarterly option: from $525 upfront.

Illinois tax extra; confirm the prescribed tier.

Full price details

$195/month; higher-dose tier $265/month; quarterly from $525 upfront; Illinois tax extra

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Medication-specific quote required

Tirzepatide appears in the clinical FAQ.

A separate price is not established; confirm before paying.

Full price details

Listed in current clinical FAQ; separate medication-specific price requires confirmation

CoverageUS only; restrictions by state, confirmed at intakeFL, IL, IN, MI, NY and PA
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

LIV by WellNow: Confirm the prescribed medication and dose tier. Quarterly payment is upfront, and Illinois tax is additional.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.